Angela Lamarca, MD, PhD

Fundacion Jimenez Diaz University Hospital
Madrid, Spain

Dr Angela Lamarca is a Medical Oncologist (MD, PhD, MSc), specialised in gastrointestinal malignancies (hepato-pancreato-biliary (HPB) and neuroendocrine tumours (NETs)). She completed her training in Medical Oncology (including her PhD) in Spain (Hospital Universitario La Paz, Madrid). She moved to The Christie NHS Foundation Trust (Manchester, United Kingdom) in 2013, where she completed a 4-year fellowship programme in HPB and NETs. Dr Lamarca has completed a Masters Degree in Molecular Biology of Cancer and a second Masters Degree in Biostatistics. She was awarded with an American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award in 2017 and was appointed as a Consultant in Medical Oncology at The Christie NHS Foundation Trust in May 2018 where she practiced until May 2022, when she moved back to Madrid (Spain; Fundacion Jimenez Diaz University Hospital) to continue her clinical and research activities in HPB and NETs. Dr Angela Lamarca is a member of the EORTC Gastrointestinal Cancer Group, ENETS Advisory board and a faculty member of the ESMO Non-Colorectal Gastrointestinal Cancer group.

Presentation(s):

• Case Study Discussion of BTC Diagnosis

  Wednesday, June 29, 2022
  11:30 – 11:45

• Panel Discussion on Biomarkers in BTC

  Wednesday, June 29, 2022
  11:55 – 12:05

• Key Challenges in the Management of Patients with BTC

  Wednesday, June 29, 2022
  12:05 – 12:15

• Panel Discussion on Prospects for BTC Care

  Wednesday, June 29, 2022
  12:15 – 12:30

• Q&A Session

  Wednesday, June 29, 2022
  12:30 – 12:45

• Session III: Cancer of the Biliary Tract

  Wednesday, June 29, 2022
  16:40 – 18:45

• Cases With Panel Discussion: Locally Advanced Biliary Tract Cancer

  Wednesday, June 29, 2022
  16:55 – 17:15

• Cases With Panel Discussion: NGS as the First-line Treatment in All Patients With Advanced Bile Duct Cancer

  Wednesday, June 29, 2022
  18:10 – 18:35

• Q&A and Panel Discussion

  Wednesday, June 29, 2022
  18:35 – 18:45

• HPB and Pancreatic Cancers: Personalised Strategies

  Wednesday, June 29, 2022
  20:05 – 20:15

• WCGIC Colloquium 3: NET Tumors

  Thursday, June 30, 2022
  18:50 – 19:50

• Changing Treatment Landscape in Cholangiocarcinoma: What is the Role of Molecular Testing

  Friday, July 1, 2022
  14:30 – 14:50

• Conclusion and Q&A

  Friday, July 1, 2022
  14:50 – 15:10